Super-sensitive bifunctional nanoprobe: Self-assembly of peptide-driven nanoparticles demonstrating tumor fluorescence imaging and therapy

The development of nanomedicine has recently achieved several breakthroughs in the field of cancer treatment; however, biocompatibility and targeted penetration of these nanomaterials remain as limitations, which lead to serious side effects and significantly narrow the scope of their application. T...

Full description

Saved in:
Bibliographic Details
Main Authors: Han Xiao (Author), Rui Zhang (Author), Xiaobo Fan (Author), Xinglu Jiang (Author), Mingyuan Zou (Author), Xuejiao Yan (Author), Haiping Hao (Author), Guoqiu Wu (Author)
Format: Book
Published: Elsevier, 2022-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_4ab1f7769cac4c8f8c64a2d56bdc5a5a
042 |a dc 
100 1 0 |a Han Xiao  |e author 
700 1 0 |a Rui Zhang  |e author 
700 1 0 |a Xiaobo Fan  |e author 
700 1 0 |a Xinglu Jiang  |e author 
700 1 0 |a Mingyuan Zou  |e author 
700 1 0 |a Xuejiao Yan  |e author 
700 1 0 |a Haiping Hao  |e author 
700 1 0 |a Guoqiu Wu  |e author 
245 0 0 |a Super-sensitive bifunctional nanoprobe: Self-assembly of peptide-driven nanoparticles demonstrating tumor fluorescence imaging and therapy 
260 |b Elsevier,   |c 2022-03-01T00:00:00Z. 
500 |a 2211-3835 
500 |a 10.1016/j.apsb.2021.07.020 
520 |a The development of nanomedicine has recently achieved several breakthroughs in the field of cancer treatment; however, biocompatibility and targeted penetration of these nanomaterials remain as limitations, which lead to serious side effects and significantly narrow the scope of their application. The self-assembly of intermediate filaments with arginine-glycine-aspartate (RGD) peptide (RGD-IFP) was triggered by the hydrophobic cationic molecule 7-amino actinomycin D (7-AAD) to synthesize a bifunctional nanoparticle that could serve as a fluorescent imaging probe to visualize tumor treatment. The designed RGD-IFP peptide possessed the ability to encapsulate 7-AAD molecules through the formation of hydrogen bonds and hydrophobic interactions by a one-step method. This fluorescent nanoprobe with RGD peptide could be targeted for delivery into tumor cells and released in acidic environments such as endosomes/lysosomes, ultimately inducing cytotoxicity by arresting tumor cell cycling with inserted DNA. It is noteworthy that the RGD-IFP/7-AAD nanoprobe tail-vein injection approach demonstrated not only high tumor-targeted imaging potential, but also potent antitumor therapeutic effects in vivo. The proposed strategy may be used in peptide-driven bifunctional nanoparticles for precise imaging and cancer therapy. 
546 |a EN 
690 |a Nanoprobe 
690 |a 7-Amino actinomycin D 
690 |a Intermediate filament protein 
690 |a Tumor image 
690 |a Antitumor therapy 
690 |a Integrin αvβ3 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Acta Pharmaceutica Sinica B, Vol 12, Iss 3, Pp 1473-1486 (2022) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S2211383521002690 
787 0 |n https://doaj.org/toc/2211-3835 
856 4 1 |u https://doaj.org/article/4ab1f7769cac4c8f8c64a2d56bdc5a5a  |z Connect to this object online.